Haploidentical Stem Cell Transplant With Post Transplant Cyclophosphamide for Chronic Granulomatous Disease With Thiotepa, Busulfan, and Fludarabine as Conditioning

被引：1
|
作者：
Kapoor, Rohit [1 ]
Rastogi, Neha [1 ]
Yadav, Satya P. [1 ]
机构：
[1] Medanta Medicity Hosp, Canc Inst, Pediat Hematol Oncol & Bone Marrow Transplant Uni, Gurgaon, Haryana, India
来源：
JOURNAL OF PEDIATRIC HEMATOLOGY ONCOLOGY | 2021年 / 43卷 / 04期
关键词：
SURVIVAL;
D O I：
10.1097/MPH.0000000000002015
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：155 / 156
页数：2
相关论文
共 50 条
  • [1] Haploidentical Stem Cell Transplant with Post-Transplant Cyclophosphamide with Busulfan, Fludarabine and Thiotepa Conditioning for Children with Thalassemia Major
    Yadav, Satya Prakash
    Sharma, Anil
    Kapoor, Rohit
    Chatterjee, Goutomi
    Rastogi, Neha
    BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION, 2020, 26 (03) : S218 - S219
  • [2] Successful Haploidentical Stem Cell Transplant with Busulfan, Fludarabine, Thiotepa Conditioning and Post Transplant Cyclophosphamide, Cyclosporine and Mycophenolate Mofetil in an Infant with Thalassemia Major
    Yadav, Satya Prakash
    Nivargi, Sagar
    Thakkar, Dhwanee
    Sharma, Anil
    Rastogi, Neha
    BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION, 2019, 25 (03)
  • [3] Successful haploidentical stem cell transplant with post transplant cyclophosphamide in chronic granulomatous disease
    Yadav, Satya Prakash
    Sharma, Anil
    Nivargi, Sagar
    Thakkar, Dhwanee
    Rastogi, Neha
    BONE MARROW TRANSPLANTATION, 2019, 54 : 393 - 393
  • [4] Haploidentical Hematopoietic Stem Cell Transplant For Sickle Cell Disease Using Thiotepa Based Reduced Intensity Conditioning And Post Transplant Cyclophosphamide
    Kharya, D. G.
    Doval, D.
    Chaudhary, D. R.
    Dhamija, M.
    Khandelwal, V.
    Lunkad, S.
    Setia, R.
    Handoo, A.
    Sharma, S.
    Dadu, T.
    BONE MARROW TRANSPLANTATION, 2015, 50 : 5556 - 5557
  • [5] Haploidentical hematopoietic stem cell transplant for patients with sickle cell disease using thiotepa, fludarabine, thymoglobulin, low dose cyclophosphamide, 200 cGy tbi and post transplant cyclophosphamide
    Haydar Frangoul
    Misty Evans
    Julie Isbell
    Katie Bruce
    Jennifer Domm
    Bone Marrow Transplantation, 2018, 53 : 647 - 650
  • [6] Haploidentical hematopoietic stem cell transplant for patients with sickle cell disease using thiotepa, fludarabine, thymoglobulin, low dose cyclophosphamide, 200 cGy tbi and post transplant cyclophosphamide
    Frangoul, Haydar
    Evans, Misty
    Isbell, Julie
    Bruce, Katie
    Domm, Jennifer
    BONE MARROW TRANSPLANTATION, 2018, 53 (05) : 647 - 650
  • [7] HAPLOIDENTICAL RELATED DONOR PERIPHERAL BLOOD STEM CELL TRANSPLANT FOR THALASSEMIA MAJOR WITH POST TRANSLANT CYCLOPHOSPHAMIDE AND THIOTEPA, FLUADARABNE AND TREOSULFAN OR BUSULFAN CONDITIONING
    Yadav, Satya Prakash
    Thakkar, Dhwanee
    Upasana, K.
    Arora, Sunisha
    Khandewal, Rachit
    Rastogi, Neha
    BONE MARROW TRANSPLANTATION, 2023, 58 (SUPP1) : 389 - 390
  • [8] The role of anti-thymocyte globulin withthiotepa-Busulfan-Fludarabine based conditioning in patients undergoing haploidentical stem cell transplant and post-transplant cyclophosphamide
    El Cheikh, Jean
    Devillier, Raynier
    Dulery, Remy
    Massoud, Radwan
    Moukalled, Nour
    Ghaoui, Nohra
    Pagliardini, Thomas
    Marino, Fabrizio
    Bazarbachi, Ali
    Castagna, Lucas
    Mohty, Mohammad
    Blaise, Didier
    BONE MARROW TRANSPLANTATION, 2019, 54 : 55 - 55
  • [9] Thiotepa Based Conditioning for Haploidentical Stem Cell Transplantation with Post Transplant Cyclophosphamide for Pediatric Acute Leukemia Is Highly Effective
    Yadav, Satya Prakash
    Sharma, Anil
    Kapoor, Rohit
    Chatterjee, Goutomi
    Thakkar, Dhwanee
    Rastogi, Neha
    BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION, 2020, 26 (03) : S163 - S164
  • [10] Thiotepa, Fludarabine, and Busulfan Conditioning Regimen before T Cell Replete Haploidentical Transplantation with Post-Transplant Cyclophosphamide for Acute Myeloid Leukemia: A Bicentric Experience of 100 Patients
    Pagliardini, Thomas
    Castagna, Lucas
    Harbi, Samia
    Della Porta, Matteo
    Rey, Jerome
    Furst, Sabine
    Bramanti, Stefania
    Saillard, Colombe
    Legrand, Faezeh
    Maisano, Valerio
    Faucher, Catherine
    Granata, Angela
    Hospital, Marie-Anne
    Wang Lining
    Weiller, Pierre-Jean
    Calmels, Boris
    Charbonnier, Aude
    Lemarie, Claude
    Chabannon, Christian
    Vey, Norbert
    Mokart, Djamel
    Blaise, Didier
    Devillier, Raynier
    BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION, 2019, 25 (09) : 1803 - 1809
12345